FormFactor earnings missed by $0.03, revenue topped estimates

FormFactor (NASDAQ: FORM) reported mixed second-quarter results, with EPS of $0.27 missing analyst estimates of $0.30, while revenue of $195.8 million surpassed the $190.17 million consensus. Despite the revenue beat, the company has faced significant negative analyst sentiment, evidenced by seven negative EPS revisions in the last 90 days. The stock's performance reflects this volatility, with a 13.75% gain over the last three months contrasting with a 35.74% decline over the past year.

Analysis

FormFactor (FORM) delivered mixed second-quarter results, characterized by a top-line beat and a bottom-line miss. The company reported revenue of $195.8 million, surpassing the consensus estimate of $190.17 million, but its EPS of $0.27 fell short of the $0.30 analyst forecast. This suggests potential margin pressure or higher-than-expected costs are offsetting revenue strength. The negative sentiment from the analyst community is a significant headwind, evidenced by seven negative EPS revisions and no positive revisions in the last 90 days. This bearish outlook contrasts with an InvestingPro financial health score of "good performance," indicating underlying fundamental stability. The stock's performance reflects this conflicting picture, with a 13.75% gain in the last three months failing to reverse a steep -35.74% decline over the past year, highlighting significant investor uncertainty and market volatility for the name.

Key Decisions for Investors

• Investors should weigh the encouraging revenue outperformance against the EPS miss and the decidedly negative trend in analyst revisions, which signal potential near-term risks to profitability.
• Given the stock's significant volatility, characterized by a 13.75% recent gain but a -35.74% annual decline, positions should be managed with caution, paying close attention to forward guidance and cost management.
• Before establishing or adding to a position, it would be prudent to investigate the drivers behind the "good performance" financial health score to ascertain if the company's balance sheet can withstand the negative earnings sentiment.